Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Zhangsheng, Xiao"'
Publikováno v:
Experimental and Therapeutic Medicine. 23
The transcription factor, forkhead box P2 (FOXP2) has tumor-suppressive effects in several types of cancer. However, the regulatory role and underlying mechanism of FOXP2 in thyroid cancer (THCA) is not completely understood. In the present study, th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e97dd205e7d462161bb848cdfe69526d
https://doi.org/10.3892/etm.2022.11361
https://doi.org/10.3892/etm.2022.11361
Publikováno v:
Medicine. 101:e29899
Background: Totally implantable venous access ports (TIVAP) have become important infusion channels for children with tumors. With the popularization of TIVAP, its related complications have gradually received clinical attention. However, few studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06cec6b61bffdcc8f7971d2427bb8c86
https://doi.org/10.1097/md.0000000000029899
https://doi.org/10.1097/md.0000000000029899
Autor:
Jiagen, Li, Zhangsheng, Xiao, Xianjie, Hu, Yun, Li, Xing, Zhang, Songze, Zhang, Weikun, Gong, Jianqiang, Zhao, Xuemei, Ye
Publikováno v:
Pharmacology. 99(3-4)
The purpose of this study is to examine the effectiveness of introducing both rituximab (RTX) and 131I for active Graves' ophthalmopathy (GO) with hyperthyroidism.In total, 217 patients suffering from active GO with hyperthyroidism were included in t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::211b30cb970095c8672edc92e01dc949
https://pubmed.ncbi.nlm.nih.gov/28049190
https://pubmed.ncbi.nlm.nih.gov/28049190